Cargando…

The radiosensitivity index predicts for overall survival in glioblastoma

We have previously developed a multigene expression model of tumor radiosensitivity (RSI) with clinical validation in multiple cohorts and disease sites. We hypothesized RSI would identify glioblastoma patients who would respond to radiation and predict treatment outcomes. Clinical and array based g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Kamran A., Chinnaiyan, Prakash, Fulp, William J., Eschrich, Steven, Torres-Roca, Javier F., Caudell, Jimmy J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741462/ https://www.ncbi.nlm.nih.gov/pubmed/26451615

Ejemplares similares

Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization
por: Yang, George, et al.
Publicado: (2021)

Applying Metabolomics to Understand the Aggressive Phenotype and Identify Novel Therapeutic Targets in Glioblastoma
por: Ahmed, Kamran A., et al.
Publicado: (2014)

A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation
por: Prokopiou, Sotiris, et al.
Publicado: (2015)

Comorbid Medical Conditions as Predictors of Overall Survival in Glioblastoma Patients
por: Carr, Matthew T., et al.
Publicado: (2019)

Radioresistance in Glioblastoma and the Development of Radiosensitizers
por: Ali, Md Yousuf, et al.
Publicado: (2020)

Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma
por: Beig, Niha, et al.
Publicado: (2018)

MGMT methylation may benefit overall survival in patients with moderately vascularized glioblastomas
por: Fuster-Garcia, Elies, et al.
Publicado: (2020)

Functional connectivity within glioblastoma impacts overall survival
por: Daniel, Andy G S, et al.
Publicado: (2020)

Overall Survival Prediction in Glioblastoma With Radiomic Features Using Machine Learning
por: Baid, Ujjwal, et al.
Publicado: (2020)

A new class of radiosensitizers for glioblastoma
por: Abounader, Roger, et al.
Publicado: (2021)

Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization
por: Rath, Barbara H, et al.
Publicado: (2015)

Leukopenia is a biomarker for effective temozolomide dosing and predicts overall survival of patients with glioblastoma
por: Ho, K. Grace, et al.
Publicado: (2020)

Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy
por: Pasqualetti, Francesco, et al.
Publicado: (2022)

Angiogenin Upregulation Independently Predicts Unfavorable Overall Survival in Proneural Subtype of Glioblastoma
por: Hu, Ji-liang, et al.
Publicado: (2019)

Glioblastoma cell differentiation trajectory predicts the immunotherapy response and overall survival of patients
por: Wang, Zihao, et al.
Publicado: (2020)

Machine Learning and Radiomic Features to Predict Overall Survival Time for Glioblastoma Patients
por: Chato, Lina, et al.
Publicado: (2021)

Notch1 ablation radiosensitizes glioblastoma cells
por: Han, Na, et al.
Publicado: (2017)

Novel Strategies for Nanoparticle-Based Radiosensitization in Glioblastoma
por: Ruiz-Garcia, Henry, et al.
Publicado: (2021)

Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers
por: Zoi, Vasiliki, et al.
Publicado: (2022)

Dodecafluoropentane Emulsion as a Radiosensitizer in Glioblastoma Multiforme
por: Lickliter, Jason D., et al.
Publicado: (2023)

MRI phenotypes of glioblastomas early after treatment are suggestive of overall patient survival
por: Schmitz-Abecassis, Bárbara, et al.
Publicado: (2023)

PSMA Expression Correlates with Improved Overall Survival and VEGF Expression in Glioblastoma
por: Yuile, Alexander, et al.
Publicado: (2023)

Simulation of intrafraction motion and overall geometric accuracy of a frameless intracranial radiosurgery process
por: Feygelman, Vladimir, et al.
Publicado: (2008)

Expression of TMEM59L associated with radiosensitive in glioblastoma
por: Gao, Dezhi, et al.
Publicado: (2023)

Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastoma
por: Fathi Kazerooni, Anahita, et al.
Publicado: (2022)

A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma
por: Zhang, Chaocai, et al.
Publicado: (2021)

Identification of an IFN-β-associated gene signature for the prediction of overall survival among glioblastoma patients
por: Cheng, Lijing, et al.
Publicado: (2021)

Phospho-AXL is widely expressed in glioblastoma and associated with significant shorter overall survival
por: Onken, Julia, et al.
Publicado: (2017)

Association of graph-based spatial features with overall survival status of glioblastoma patients
por: Lee, Joonsang, et al.
Publicado: (2023)

Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma
por: Gleeson, Jack Patrick, et al.
Publicado: (2019)

Diffusion MRI Characteristics After Concurrent Radiochemotherapy Predicts Progression-Free and Overall Survival in Newly Diagnosed Glioblastoma
por: Chang, Warren, et al.
Publicado: (2015)

Integrating Biological Covariates into Gene Expression-Based Predictors of Radiation Sensitivity
por: Kamath, Vidya P., et al.
Publicado: (2017)

Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experience
por: Oliver, Daniel E, et al.
Publicado: (2018)

Multiomics Differences in Lung Squamous Cell Carcinoma Patients with High Radiosensitivity Index Compared with Those with Low Radiosensitivity Index
por: Du, Yajing, et al.
Publicado: (2021)

Antibody Delivery into the Brain by Radiosensitizer Nanoparticles for Targeted Glioblastoma Therapy
por: Gal, Omer, et al.
Publicado: (2022)

The Combination of Metformin and Disulfiram-Cu for Effective Radiosensitization on Glioblastoma Cells
por: Rezaei, Narges, et al.
Publicado: (2020)

Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma
por: Degorre, Charlotte, et al.
Publicado: (2021)

MMP14 Contributes to HDAC Inhibition-Induced Radiosensitization of Glioblastoma
por: Zhou, Yuchuan, et al.
Publicado: (2021)

MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy
por: Miles, Xanthene, et al.
Publicado: (2021)

A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinoma
por: Ho, Emily, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rail1j1iqfa4qg7dsumdh1kqu4